Review Article
Austin Pediatr. 2017; 4(1): 1049.
Cerebrospinal Fluid Cytokines in Diagnosis of Acute Bacterial Meningitis
Aggrawal P, Agrawal A and Prasad R*
Department of Pediatrics, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India
*Corresponding author: Prasad R, Department of Pediatrics, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India
Received: January 15, 2017; Accepted: February 13, 2017; Published: February 15, 2017
Abstract
Acute bacterial meningitis in children is associated with high mortality and morbidity in developing countries including India due to poor immunization coverage, delayed diagnosis and lack of appropriate treatment. Although Cerebrospinal Fluid (CSF) microscopic and routine examination has been used as a tool to diagnose bacterial meningitis, it has poor sensitivity and specificity. Detection of cytokines such as TNF a, IL-6 and IL-8 in the CSF has been suggested for early diagnosis and differentiation of various etiological subgroups of meningitis. This review aims to summarize the diagnostic performance of these cytokines for the same in various studies in existing literature.
Keywords: Meningitis; Tumour Necrosis Factor (TNF-a); Interleukin- 6(IL-6); IL-8
Introduction
Acute Bacterial Meningitis is a life threatening condition associated with high mortality and morbidity. Although bacterial meningitis account for only minority (approximately 5%) of the total cases, it is the most severe form and associated with mortality ranging from 2% in infants and children to as high as 30% in neonates and adults [1,2]. The case fatality rates are even worse in developing countries with various reported mortality rates of 37 to 60% despite use of appropriate therapeutic and diagnostic advancements in contrast to the developed nations. The difference in mortality can be attributed to poor immunization coverage, delayed diagnosis and lack of appropriate treatment in developing countries. Patients who survive, 1/3rd are left with various neurological sequelae such as deafness, blindness, motor deficit or cognitive impairment [3].
The diagnosis of bacterial meningitis although primarily relies upon CSF examination [4], has poor sensitivity and specificity in differentiating the etiological subgroups [5], Clinical assessment, cytology, CSF culture, Gram’s staining, biochemical test and newer tests such as CSF CRP, serum procalcitonin, CSF cytokines and CSF PCR have been used to diagnose and differentiate bacterial from nonbacterial causes of meningitis. As none of these tests is unequivocally optimal, empirical use of antibiotics have resulted in unnecessary hospitalization and increased cost [4-6].
Cytokines in Diagnosis
Cytokines (mainly TNF a, IL6 and IL8), chemokines, proteolytic enzymes, and oxidants play an important role in inflammatory cascade and brain dysfunction associated with bacterial meningitis [7]. Tumor necrosis factor-alpha (TNF-a) is a potent activator of neutrophils and mediates adherence, chemo taxis, degranulation, and the respiratory burst. Interleukin-6 (IL-6) stimulates the growth of B lymphocytes that have differentiated into antibody producing cells. Interleukin-8 (IL-8) acts as a chemo attractant for neutrophils to the site of inflammation. IL-6-deficiency has been shown to result in higher CNS bacterial colonization and lower survival in murine model [8]. A higher concentration of TNF-a, IL-6 and IL-8 in patients with bacterial meningitis has been reported in various studies and has been successfully used in early diagnosis as well as differentiating bacterial and viral meningitis [9]. Various studies have found them to be the most sensitive and specific inflammatory markers of bacterial meningitis [10,11].
Literature Review on Cytokines
Cytokines such as tumor necrosis factor (TNF)-a, interleukin (IL)-1β, IL-8, and IL-6 are expressed in the CNS after local bacteria inoculation and are detectable up to 96 hours [12,13]. The elevated levels of these cytokines in the CSF, implies their role in the pathogenesis of bacterial meningitis and can be used in diagnosis and monitoring the treatment response. No association of these cytokines has been reported with the subsequent development of neurological sequelae. Studies have indicated that elevated levels of these cytokines may not be evident in the serum, as their expression may be a local and compartmentalized phenomenon [14].
A significant increase in CSF cytokines levels in the cases of meningitis has been demonstrated in many studies, adding to the diagnostic potential of their analysis.12-14 Most significant of these cytokines are TNF-a, IL-6 and IL-8 [15,16]. Although there are few studies that failed to reveal a statistically significant difference in IL-6 levels between meningitis and non- meningitis groups, but the substantial evidence suggesting significant association cannot be neglected [17,18]. It should be noted that there have been studies reporting elevation of CSF IL-6 in patients of traumatic brain injuries as well, however can easily excluded by a careful clinical history [19]. The elevated cytokines levels can be used to differentiate between bacterial, viral and tubercular etiology as studies have shown higher levels of cytokine (TNF- a, IL-6 and IL-8) in acute bacterial meningitis compared to others [20,21]. These studies have revealed sensitivity and specificity approaching 100%, making this test highly valuable [22-24].
Few studies that assessed each cytokine level individually, failed to demonstrate a significant differences between septic and aseptic meningitis [17,19,25] As there is a positive significant association between different cytokines14, a battery of tests consisting of TNF- a, IL-6 and IL-8 can be done to alleviate any confusion or false negative results. There is no evidence of any association between cytokines and routinely measured CSF parameters [14,21]. These tests can also be performed to differentiate between lymphocytic predominant meningitis and partially treated septic meningitis with high sensitivity and specificity [22], however no significant association has been found between meningitis causing bacterial species and CSF cytokine values (Table 1).
Study
Year
Sample size
(Bacterial Meningitis)
Sample size
(Non Bacterial Meningitis)
Assay Method
Cut off value
Sensitivity
(%)
Specificity
(%)
TNF a
Nadal D et al [28]
1989
18
31
ELISA
500 pg/ml
NA
NA
Glimâker M et al [29]
1993
51
78
Tang RB et al [11]
2001
23
26
74
81
Mukai AO et al [15]
2006
6
13
ELISA
Prasad R et al [20]
2014
57
30
ELISA
500 pg/ml
100
100
IL-6
Dulkerian SJ et al [30]
1995
20
42
ELISA
NA
100
79
Hashim IA et al [31]
1995
123
123
Radioimmunoassay
3.4 ng/ml
93
95
Kleine TO et al [32]
2003
40
46
SPSCI
2500 ng/ml
92
93
Hsieh CC et al [24]
2009
12
41
ELISA
10 pg/ml
92
51
Chen Z et al [33]
2012
22
61
Radioimmunoassay
51.6 ng/ml
64
95
Vázquez JA et al [26]
2012
13
27
ELISA
90 pg/ml
92
100
Takahashi W et al [22]
2014
13
57
CLEIA
644 pg/ml
92
89
Prasad R et al [20]
2014
57
30
ELISA
100 pg/ml
96
100
IL-8
Ostergaard C et al [34]
1996
31
13
ELISA
3μg/L
81
92
Kleine TO et al [32]
2003
40
46
SPSCI
4000 ng/L
48
91
Pinto Junior VL et al [35]
2011
9
18
ELISA
1.685 ng/dl
100
94
Chen Z [33]
2012
22
61
Radioimmunoassay
1.14 pg/ml
91
67
Prasad R et al [20]
2014
57
30
ELISA
75 pg/ml
100
100
Abdelmoez AT et al [23]
2014
40
40
ELISA
3.6 ng/ml
83
85
Table 1: Various studies validating usefulness of TNF-a, IL-6 and IL-8 in establishing etiology of Meningitis in children.
Prognostic Significance
IL-6 levels in CSF has been shown to be directly proportional to the severity of illness but no significant association was found between IL-8 and disease severity [14,21]. The literature also reports a decline in CSF cytokines IL-6, IL-8 and TNF-a levels on serial measurements after initiation of treatment closely correlated with the clinical improvement of the corresponding patients [14,19,21]. In the subgroup of patents not responsive to treatment, the cytokines levels failed to decrease during the serial measurements, and was associated with higher mortality and poorer prognosis [21,26,27]. These findings suggest a role of serial CSF cytokine measurement in monitoring the clinical outcome and treatment of meningitis [19,28-35].
Conclusion
Cytokine estimation is a fast, easy, and reliable test which can be used to differentiate between the etiological factors, monitor treatment and prognosticate the therapeutic outcome in cases of meningitis. However, higher cost, non standardization of the cut-off values and decreased level of awareness limits its routine application in daily clinical practice in the developing countries. Moreover, the standardization of the cutoff value of these tests is required before widespread implementation.
References
- Nigrovic LE, Kuppermann N, Macias CG, et al. Clinical prediction rule for identifying children with cerebrospinal fluid pleocytosis at very low risk of bacterial meningitis. JAMA. 2007; 297: 52-60.
- Dubos F, Lamotte B, Bibi-Triki F, et al. Clinical decision rules to distinguish between bacterial and aseptic meningitis. Arch Dis Child. 2006; 91: 647-650.
- Neuman HB, Wald ER. Bacterial meningitis in childhood at the Children’s Hospital of Pittsburgh: 1988e1998. Clin Pediatr. 2001; 40: 595-600.
- Dubos F, Korczowski B, Aygun DA, et al. Serum procalcitonin level and other biological markers to distinguish between bacterial and aseptic meningitis in children: a European multicentre case cohort study. Arch Pediatr Adolesc Med. 2008; 162: 1157-1163.
- Parasuraman TV, Frenia K, Romero J. Enteroviral meningitis: cost of illness and considerations for the economic evaluation of potential therapies. Pharmacoeconomics. 2001; 19: 3-12.
- Khetsuriani N, Quiroz ES, Holman RC, Anderson LJ. Viral meningitis associated hospitalizations in the United States, 1988-1999. Neuroepidemiol. 2003; 22: 345-352.
- Koedel U, Scheld WM, Pfister HW. Pathogenesis and pathophysiology of pneumococcal meningitis. Lancet Infect Dis. 2002; 2: 721-736.
- van der Poll T, Keogh CV, Guirao X, et al. Interleukin-6 gene-deficient mice show impaired defense against pneumococcal pneumonia. J Infect Dis. 1997; 176: 439–444.
- Mustafa MM, Ramilo O, Saez-Liorens X et al. Role of tumor necrosis factor alpha (cachectin) in experimental and clinical bacterial meningitis. Pediatr Infect Dis J. 1989; 8: 907-908.
- Tsai ML, Chen WC, Wang YC, Hung KL. Cerebrospinal fluid interleukin-6, interleukin-8, and tumor necrosis factor-alpha in children with central nervous system infections. Zhonghua Minguo Xiao Er Ke Yi Xue Hui. 1996; 37: 16-21.
- Tang RB, Lee BH, Chung RL, Chen SJ, Wong TT. Interleukin-1beta and tumor necrosis factor-alpha in cerebrospinal fluid of children with bacterial meningitis. Childs Nerv Syst. 2001; 17: 453-456.
- Barichello T, dos Santos I, Savi GD, et al. TNF-alpha, IL-1beta, IL-6, and cinc- 1 levels in rat brain after meningitis induced by Streptococcus pneumoniae. J Neuroimmunol. 2010; 221: 42–45.
- Barichello T, Lemos JC, Generoso JS, et al. Oxidative stress, cytokine/ chemokine and disruption of blood-brain barrier in neonate rats after meningitis by Streptococcus agalactiae. Neurochem Res. 2011; 36: 1922– 1930.
- Jain M, Aneja S, Mehta G et al. CSF interleukin-1ß, tumor necrosis factoralpha and free radicals production in relation to clinical outcome in acute bacterial meningitis. Indian Pediatr. 2000; 37: 608-614.
- Mukai AO, Krebs VL, Bertoli CJ, Okay TS. TNF-alpha and IL-6 in the diagnosis of bacterial and aseptic meningitis in children. Pediatr Neurol. 2006; 34: 25-29.
- Yilmaz E, Gürgöze MK, Ilhan N et al. Interleukin-8 levels in children with bacterial, tuberculous and aseptic meningitis. Indian J Pediatr. 2002; 69: 219- 221.
- Handa S. Concentrations of Interleukin-1a, Interleukin-6, Interleukin-8 and TNF-a in Cerebrospinal Fluid from Children with Septic or Aseptic Meningitis. The Kurume Medical Journal. 1992; 39: 257-265.
- Fida NM, Al-Mughales JA, Fadelallah MF. Serum concentrations of interleukin-1 alpha, interleukin-6 and tumor necrosis factor-alpha in neonatal sepsis and meningitis. Saudi Med J. 2006; 27: 1508-1514.
- Kepa L, Oczko-Grzesik B, Boron-Kaczmarska A. Cerebrospinal fluid interleukin-6 Concentration in patients with purulent, bacterial meningitis – own observations. Przegl Epidemiol. 2014; 68: 645 – 649.
- Prasad R, Kapoor R, Srivastava R, Mishra OP, Singh TB. Cerebrospinal Fluid TNF-a, IL-6, and IL-8 in Children with Bacterial Meningitis. Pediatric Neurol. 2014; 50: 60-65.
- Perrella O , Rescigno C , Guarnaccia D et al. Cerebrospinal fluid interleukin-6 and IgE in bacterial and viral meningitis. Acta Neurologica. 1992; 14: 6-9.
- Takahashi W, Nakada TA, Abe R et al. Usefulness of interleukin 6 levels in the cerebrospinal fluid for the diagnosis of bacterial meningitis. J Crit Care. 2014; 29: 693.
- Abdelmoez AT, Zaky DZ, Maher AM. Role of cerebrospinal fluid IL-8 as a marker for differentiation between acute bacterial and aseptic meningitis. J Egypt Soc Parasitol. 2014; 44: 205-210.
- Hsieh CC, Lu JH, Chen SJ et al. Cerebrospinal fluid levels of interleukin-6 and interleukin-12 in children with meningitis. Childs Nerv Syst. 2009; 25: 461-465.
- Gendrel D, Raymond J, Assicot M, et al. Procalcitonin, C-reactive protein and interleukin 6 in bacterial and viral meningitis in children. Presse Med. 1998; 27: 1135-1139.
- Vazquez JA, Adducci Mdel C, Coll C, et al. Acute meningitis prognosis using cerebrospinal fluid interleukin-6 levels. J Emerg Med. 2012; 43: 322–327.
- Grandgirard D, Gaumann R, Coulibaly B, et al. The causative pathogen determines the inflammatory profile in cerebrospinal fluid and outcome in patients with bacterial meningitis. Mediators Inflamm. 2013; 2013: 312476.
- Nadal D, Leppert D, Frei K, Gallo P, Lamche H, Fontana A. Tumour necrosis factor u in infectious meningitis. Archives of Disease in Childhood. 1989; 64: 1274-1279.
- Glimåker M, Kragsbjerg P, Forsgren M, Olcén P. Tumor necrosis factor-alpha (TNF alpha) in cerebrospinal fluid from patients with meningitis of different etiologies: high levels of TNF alpha indicate bacterial meningitis. J Infect Dis. 1993; 167: 882-889.
- Dulkerian SJ, Kilpatrick L, Costarino AT Jr, McCawley L, Fein J, Corcoran L, Zirin S, Harris MC. Cytokine elevations in infants with bacte–rial and aseptic meningitis. J Pediatr. 1995; 126: 872-876.
- Hashim IA, Walsh A, Hart CA, Shenkin A. Cerebrospinal fluid interleukin-6 and its diag-nostic value in the investigation of meningitis. Ann Clin Biochem. 1995; 32: 289-296.
- Kleine TO, Zwerenz P, Zöfel P, Shiratori K. New and old diagnostic markers of meningitis in ce–rebrospinal fluid (CSF). Brain Res Bull. 2003; 61: 287-297.
- Chen Z, Wang Y, Zeng A, Chen L, Wu R, Chen B, et al. The clinical diagnostic significance of cerebro–spinal fluid D-lactate for bacterial meningitis. Clin Chim Acta. 2012; 413: 1512-1515.
- Ostergaard C, Benfield TL, Sellebjerg F, Kron-borg G, Lohse N, Lundgren JD. Interleukin-8 in cerebrospinal fluid from patients with septic and aseptic meningitis. Eur J Clin Microbiol Infect Dis. 1996; 15: 166-169.
- Pinto Junior VL, Rebelo MC, Gomes RN, Assis EF, Castro-Faria-Neto HC, Bóia MN. IL-6 and IL-8 in cerebrospinal fluid from patients with aseptic meningitis and bacterial meningitis: their potential role as a marker for differential diagnosis. Braz J Infect Dis. 2011; 15: 156-158.